Medical Technology

@xconomy.com 4 years ago

Five Years After Y Combinator First Admits Biotechs, They’re Dug In

@xconomy.com 4 years ago

Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further

@xconomy.com 5 years ago

After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval

@xconomy.com 5 years ago

After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals

@xconomy.com 5 years ago

After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield

@xconomy.com 5 years ago

Andreessen Leads $300M Bet on Devoted Health’s Senior Care Approach

@xconomy.com 5 years ago

Circulation CEO Talks Sale to LogistiCare & Amazon’s Healthcare Play

@xconomy.com 5 years ago

With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?

@xconomy.com 5 years ago

Boston Scientific Continues M&A Streak with $202M Deal for Cryterion

@xconomy.com 5 years ago

Strangeworks, TMCx, SeriesX, Unchained Capital, ALTR, & More TX Tech

@xconomy.com 5 years ago

Pfizer, Merck Lead Strata Oncology’s $26M Series B Round

@xconomy.com 5 years ago

Fictiv Raises $15M To Connect Tech Innovators & Parts Manufacturers